HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Mediastinal signet-ring cell carcinoma of unknown primary: long-term survival by treatment with S-1, a novel derivative of 5-fluorouracil.

AuthorsChika Kusakari, Hiroshi Soda, Yoichi Nakamura, Hiroyuki Yamaguchi, Takeshi Kitazaki, Hirofumi Nakano, Yuichi Matsubara, Tomayoshi Hayashi, Toshiya Nagasaki, Takeshi Nagayasu, Shigeru Kohno
JournalLung cancer (Amsterdam, Netherlands) (Lung Cancer) Vol. 56 Issue 1 Pg. 139-41 (Apr 2007) ISSN: 0169-5002 [Print] Ireland
PMID17208329 (Publication Type: Case Reports, Letter)
Chemical References
  • Drug Combinations
  • S 1 (combination)
  • Tegafur
  • Oxonic Acid
  • Irinotecan
  • Cisplatin
  • Camptothecin
Topics
  • Antineoplastic Combined Chemotherapy Protocols (therapeutic use)
  • Camptothecin (administration & dosage, analogs & derivatives)
  • Carcinoma, Signet Ring Cell (diagnosis, drug therapy, radiotherapy)
  • Cisplatin (administration & dosage)
  • Combined Modality Therapy
  • Diagnosis, Differential
  • Drug Combinations
  • Humans
  • Irinotecan
  • Male
  • Mediastinal Neoplasms (diagnosis, drug therapy, radiotherapy)
  • Middle Aged
  • Oxonic Acid (administration & dosage)
  • Tegafur (administration & dosage)
  • Tomography, X-Ray Computed

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: